These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11972486

  • 21. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

  • 22. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 23. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
    Seguí R, Estellés A, Mira Y, España F, Villa P, Falcó C, Vayá A, Grancha S, Ferrando F, Aznar J.
    Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191
    [Abstract] [Full Text] [Related]

  • 24. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K, Herbepin VG, Touraine R, Almawi WY, Mahjoub T.
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [Abstract] [Full Text] [Related]

  • 25. Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency.
    Katrancioglu N, Manduz S, Ozen F, Yilmaz MB, Karahan O, Ozdemir O, Berkan O.
    J Int Med Res; 2010 Sep; 38(4):1513-8. PubMed ID: 20926026
    [Abstract] [Full Text] [Related]

  • 26. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 27. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
    [Abstract] [Full Text] [Related]

  • 28. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 29. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
    Cosan D, Kurt E, Kurt H, Degirmenci I, Kuçukarabaci B, Metintas M, Kucuk MU, Gunes HV, Colak E.
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
    [Abstract] [Full Text] [Related]

  • 30. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
    Błasiak J, Smolarz B.
    Acta Biochim Pol; 2000 Aug; 47(1):191-9. PubMed ID: 10961693
    [Abstract] [Full Text] [Related]

  • 31. The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm.
    Jones K, Powell J, Brown L, Greenhalgh R, Jormsjö S, Eriksson P.
    Eur J Vasc Endovasc Surg; 2002 May; 23(5):421-5. PubMed ID: 12027469
    [Abstract] [Full Text] [Related]

  • 32. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal.
    Wiwanitkit V.
    Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012
    [Abstract] [Full Text] [Related]

  • 33. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A, Shetty S, Ghosh K, Kulkarni B.
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [Abstract] [Full Text] [Related]

  • 34. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D.
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [Abstract] [Full Text] [Related]

  • 35. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
    Malle EM, Posch-Pertl L, Renner W, Pinter-Hausberger S, Singer C, Haas A, Wedrich A, Weger M.
    Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
    [Abstract] [Full Text] [Related]

  • 36. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
    Iwai N, Shimoike H, Nakamura Y, Tamaki S, Kinoshita M.
    Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
    [Abstract] [Full Text] [Related]

  • 37. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women.
    Hindorff LA, Schwartz SM, Siscovick DS, Psaty BM, Longstreth WT, Reiner AP.
    J Cardiovasc Risk; 2002 Apr; 9(2):131-7. PubMed ID: 12006921
    [Abstract] [Full Text] [Related]

  • 38. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Apr; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 39. Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.
    Bayram B, Sayin E, Erkasap N, Onlü H, Ozkurt M, Sahin F, Türkoğlu Z.
    Rheumatol Int; 2012 Jan; 32(1):259-62. PubMed ID: 21240498
    [Abstract] [Full Text] [Related]

  • 40. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
    Yıldırım ME, Karakuş S, Kurtulgan HK, Kılıçgün H, Erşan S, Bakır S.
    Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.